236 related articles for article (PubMed ID: 25303491)
1. 11β-hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes.
Dube S; Norby BJ; Pattan V; Carter RE; Basu A; Basu R
J Clin Endocrinol Metab; 2015 Jan; 100(1):E70-6. PubMed ID: 25303491
[TBL] [Abstract][Full Text] [Related]
2. Repeated measurements of 11β-HSD-1 activity in subcutaneous adipose tissue from lean, abdominally obese, and type 2 diabetes subjects--no change following a mixed meal.
Sjöstrand M; Jansson PA; Palming J; de Schoolmeester J; Gill D; Rees A; Sjögren L; Persson T; Eriksson JW
Horm Metab Res; 2010 Oct; 42(11):798-802. PubMed ID: 20514603
[TBL] [Abstract][Full Text] [Related]
3. Hepatic 11β-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique.
Dube S; Norby B; Pattan V; Lingineni RK; Singh RJ; Carter RE; Basu A; Basu R
Diabetologia; 2014 Jul; 57(7):1446-55. PubMed ID: 24771091
[TBL] [Abstract][Full Text] [Related]
4. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
[TBL] [Abstract][Full Text] [Related]
5. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
[TBL] [Abstract][Full Text] [Related]
6. 11beta-Hydroxysteroid dehydrogenase type 1-driven cortisone reactivation regulates plasminogen activator inhibitor type 1 in adipose tissue of obese women.
Ayachi SE; Paulmyer-Lacroix O; Verdier M; Alessi MC; Dutour A; Grino M
J Thromb Haemost; 2006 Mar; 4(3):621-7. PubMed ID: 16460444
[TBL] [Abstract][Full Text] [Related]
7. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
[TBL] [Abstract][Full Text] [Related]
8. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
Paulsen SK; Pedersen SB; Fisker S; Richelsen B
Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
[TBL] [Abstract][Full Text] [Related]
9. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study.
Paulmyer-Lacroix O; Boullu S; Oliver C; Alessi MC; Grino M
J Clin Endocrinol Metab; 2002 Jun; 87(6):2701-5. PubMed ID: 12050237
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid Excess Increases Hepatic 11β-HSD-1 Activity in Humans: Implications in Steroid-Induced Diabetes.
Dube S; Slama MQ; Basu A; Rizza RA; Basu R
J Clin Endocrinol Metab; 2015 Nov; 100(11):4155-62. PubMed ID: 26308294
[TBL] [Abstract][Full Text] [Related]
11. Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue.
Lee MJ; Fried SK; Mundt SS; Wang Y; Sullivan S; Stefanni A; Daugherty BL; Hermanowski-Vosatka A
Obesity (Silver Spring); 2008 Jun; 16(6):1178-85. PubMed ID: 18388900
[TBL] [Abstract][Full Text] [Related]
12. Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway.
Basu R; Singh RJ; Basu A; Chittilapilly EG; Johnson CM; Toffolo G; Cobelli C; Rizza RA
Diabetes; 2004 Aug; 53(8):2051-9. PubMed ID: 15277385
[TBL] [Abstract][Full Text] [Related]
13. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M
J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.
Abdallah BM; Beck-Nielsen H; Gaster M
Eur J Clin Invest; 2005 Oct; 35(10):627-34. PubMed ID: 16178882
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins.
Kannisto K; Pietiläinen KH; Ehrenborg E; Rissanen A; Kaprio J; Hamsten A; Yki-Järvinen H
J Clin Endocrinol Metab; 2004 Sep; 89(9):4414-21. PubMed ID: 15356040
[TBL] [Abstract][Full Text] [Related]
16. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
Desbriere R; Vuaroqueaux V; Achard V; Boullu-Ciocca S; Labuhn M; Dutour A; Grino M
Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
[TBL] [Abstract][Full Text] [Related]
17. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
[TBL] [Abstract][Full Text] [Related]
19. Cortisol metabolism after weight loss: associations with 11 β-HSD type 1 and markers of obesity in women.
Rask E; Simonyte K; Lönn L; Axelson M
Clin Endocrinol (Oxf); 2013 May; 78(5):700-5. PubMed ID: 22233384
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls.
Gambineri A; Fanelli F; Tomassoni F; Munarini A; Pagotto U; Andrew R; Walker BR; Pasquali R
Eur J Endocrinol; 2014 Jul; 171(1):47-57. PubMed ID: 24743397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
